Where is Diabion located?

Diabion is headquartered in Mixco, Guatemala.

Where does Diabion rank among its competitors?

Diabion ranks 113th amongst 116 active competitors, of which 3 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Glucose Health, which secured $100K in Jan, 2026.

Who are the top competitors of Diabion?

Diabion's top competitors include Glucose Health, Moderate and Caelus Health. Among them, Glucose Health secured the most recent funding round in January, 2026.

Diabion - 2026 Company Profile & Competitors

Diabion is an unfunded company based in Mixco (Guatemala), founded in 2011. It operates as a Manufacturing and marketing proprietary diabetes management formula. Diabion has not raised any funding yet. The company has 116 active competitors, including 3 funded and 1 that has exited. Its top competitors include companies like Glucose Health, Moderate and Caelus Health.

Company Details

Diabion (owned by merck) is engaged in manufacturing and marketing proprietary diabetes management formula. Ingredients used to manufacture include vitamins, zinc, chromium, selenium and magnesium. Benefits of the product include sugar regulation, slow cellular aging, regulation of various enzymes and hormones, improve insulin sensitivity, increase elasticity of tissues etc. The company also sells diabion cream used for restoring normal skin function.

Website: diabion.biz
Social
Part Of

Key Metrics

Founded Year

2011

Location

Mixco, Guatemala

Stage

Unfunded

Ranked

113^th among 116 active competitors

Similar Companies

Glucose Health & 126 more

View Diabion's full profile

Diabion has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Diabion include Glucose Health, Moderate and Caelus Health. Here is the list of Top 10 competitors of Diabion, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Glucose Health 2007, Bentonville (United States), Public	Diabetic-friendly nutrition: delicious drink mixes to maintain healthy blood sugar	-	-	47/100
2nd	Moderate 2023, Hyderabad (India), Seed	Provider of botanical supplement reducing post‑meal blood sugar spikes	$115K	Innopark Ventures, Disruption Fund & 4 others	39/100
3rd	Caelus Health 2014, Heiloo (Netherlands), Series A	Developer of microbiota-based products to address cardiometabolic disorders	$2.68M	Johnson & Johnson Innovation, Innovation Industries ... & 2 others	35/100
4th	Lysulin 2017, San Diego (United States), Unfunded	Provider of supplements formulated to support healthy blood sugar and A1c	-	-	26/100
5th	CuraLife 2010, Riga (Latvia), Series A	Manufacturer of nutritional supplements for diabetes	-	Catalyst	26/100
6th	INBalance Health 2012, Wayland (United States), Funding Raised	Healthy snacks, bars, and supplements for glucose and weight management	-	-	25/100
7th	Sugarless 2023, Seattle (United States), Unfunded	Provider of a dietary supplement to manage sugar cravings	-	-	24/100
8th	RedOx + Diabetic 2016, Temecula (United States), Unfunded	Diabetic supplement provider improving health through antioxidants and vitamins	-	-	24/100
9th	A1C Guard 2023, Unfunded	Developer of herbal dietary supplements to support normal blood sugar and glucose metabolism	-	-	24/100
10th	Reducose 2015, Witney (United Kingdom), Unfunded	Provider of dietary supplements for treating diabetes	-	-	24/100
113th	Diabion 2011, Mixco (Guatemala), Unfunded	Manufacturing and marketing proprietary diabetes management formula	-	-	16/100